Mediclinic withholds dividend as it waits for buyout approval
The private hospital operator expects the deal to go through in the first quarter of 2023
16 November 2022 - 10:39
Private hospital operator Mediclinic has decided against declaring an interim dividend as it waits for the August buyout from its biggest shareholder, Remgro, in a consortium with Switzerland’s MSC Mediterranean Shipping, to go through.
“Merger control approvals have been received in Namibia, Switzerland and Cyprus, with only SA approvals outstanding,” the company said on Wednesday in its results for the six months to end-September...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.